News Releases

News & Events

News Releases

Synteract Becomes Oracle PartnerNetwork Gold Level Partner

SAN DIEGO – April 20, 2016Synteract, a leading, full-service, contract research organization (CRO), continued to enhance its technology support for clients by upgrading its safety database system to the Oracle® Argus 7.0.5 module. This module operates within Oracle’s pharmacovigilance technology platform, Oracle Argus Safety and Interchange. Synteract has become a Gold level member in the Oracle PartnerNetwork program and is also a member of the Oracle Health Sciences CRO Advantage Program as an Argus hosting provider, indicating the staff has been trained to a high level of expertise in Oracle Argus.

Oracle Argus is the premiere, safety, database platform for CROs. This Oracle Argus upgrade improves the aggregate reporting, user functionality, safety data handling, electronic data efficiency, scalability, and customization capabilities that Synteract offers its biopharma clients. The software offers state-of-the-art technology and a cleaner user interface, in addition to strong redundancy and an efficient configurable workflow for Synteract’s clients.

“Our adoption of this software and our relationship with Oracle enables us to provide richer functionalities to our clients, including more automation, customized workflow, effective electronic exchange of data, and more cost effective integration with other data sources. This can increase study efficiencies, allow for more virtually seamless exchanges of information and improve access to study information, all of which helps our clients get to decision points faster,” said Associate Director of Pharmacovigilance Systems Dean Schulenberg, Synteract. “We will continue additional upgrades and enhancements throughout 2016, bringing to our clients what they need to conduct trials safely.”

Through its membership with the Oracle Health Sciences CRO Advantage Program, Synteract is able to expand its offerings to customers. The benefits of membership include more competitive licensing prices, as well as Oracle Argus specialization training.

About Synteract
Synteract is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, immunotherapy, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy, Synteract provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates.

# # #

CONTACT:
Beth Walsh
beth@clearpointagency.com
858-724-2500

x

Contact Synteract

Tell us how to stay in touch with you:

*Required